Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 20, Issue 3, pp. 512-522
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 6, 2020
- Revision received November 12, 2020
- Accepted December 16, 2020
- Published first December 22, 2020.
Article Versions
- Previous version (December 22, 2020 - 07:03).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Jacopo Millul1,
- Christiane Krudewig2,
- Aureliano Zana1,
- Sheila Dakhel Plaza1,
- Emanuele Puca1,
- Alessandra Villa1,
- Dario Neri3, and
- Samuele Cazzamalli1,*
- 1Philochem AG, Otelfingen, Zurich, Switzerland.
- 2Laboratory for Animal Model Pathology, Universität Zürich, Zurich, Switzerland.
- 3Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland.
- ↵*Corresponding Author:
Samuele Cazzamalli, Philochem AG, Libernstrasse, 3, Otelfingen, Zurich 8112, Switzerland. Phone: 414-3544-8819; Fax: 414-3544-8809; E-mail: samuele.cazzamalli{at}philochem.ch
March 2021
Volume 20, Issue 3
Volume 20, Issue 3
Immunotherapy with Immunocytokines and PD-1 Blockade Enhances the Anticancer Activity of Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX
Jump to section
Advertisement